Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study

Area of Science:

• Psychiatry
• Neurology
• Clinical Medicine

Background:

• Electroconvulsive therapy (ECT) is typically for severe major depressive disorder (MDD).
• Limited research exists on ECT's efficacy for moderate-severity MDD.
• This study investigated ECT's effectiveness across MDD severity levels.

Purpose of the Study:

• To evaluate the efficacy of ECT in treating moderate-severity MDD.
• To compare ECT outcomes in severe versus moderate MDD patients.
• To determine if ECT is a viable option for less severe depression.

Main Methods:

• Utilized data from the PRIDE study (240 elderly MDD patients).
• Administered right unilateral ultrabrief pulse ECT combined with venlafaxine.
• Assessed depression severity using the Hamilton Depression Rating Scale (HAM-D6).

Main Results:

• Both severe and moderate MDD groups showed significant HAM-D6 score reductions.
• Remission rates were 63% for severe MDD and 75% for moderate MDD.
• No statistically significant difference in remission rates between severity groups.

Conclusions:

• ECT combined with venlafaxine is effective for moderate-severity MDD.
• Current indications for ECT may need expansion to include moderate MDD.
• Further research is warranted to confirm these findings.